Pharmaceuticals and Medical Research (TRBC)

FDA approves drug to treat Duchenne muscular dystrophy

FDA approves drug to treat Duchenne muscular dystrophy

Published 09/02/2017

A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo

The U.S. Food and Drug Administration on Thursday approved a drug made by Marathon Pharmaceuticals to treat Duchenne muscular dystrophy (DMD), a devastating muscle-wasting disease that mainly affects young boys.

[more…]

Sanderson Farms shareholder proposal on antibiotics fails

Sanderson Farms shareholder proposal on antibiotics fails

Published 09/02/2017

A Sanderson Farms Inc shareholder proposal requesting the third-largest U.S. poultry producer phase out the use of medically important antibiotics for growth promotion and disease prevention failed to pass on Thursday, the company said.

[more…]

Senators question Kaleo` $4,500 tag on opioid overdose treatment

Senators question Kaleo` $4,500 tag on opioid overdose treatment

Published 09/02/2017

U.S. Sen. Clair McCaskill (D-MO) speaks on the final night of the Democratic National Convention in Philadelphia, Pennsylvania, U.S. July 28, 2016. REUTERS/Mike Segar

U.S. Democrat Senator Claire McCaskill on Thursday asked Kaleo Pharmaceuticals to justify the more than 550 percent surge in the price of its device to treat painkiller overdoses, becoming the second senator to question Evzio's $4,500 price tag.

[more…]

Lundbeck gives up on Alzheimer`s drug, rival to Axovant pill

Lundbeck gives up on Alzheimer`s drug, rival to Axovant pill

Published 08/02/2017

Two remaining late-stage clinical trials testing an experimental Alzheimer's drug from Denmark's Lundbeck have failed, scuppering hopes for the medicine and underscoring the difficulty of developing such treatments.

[more…]